Top Tweets for #RateAF
🧵Our new paper from the #RATEAF trial in @BMCMedicine
We examined circulating cardiotonic steroids in AF and HF patients, and the results challenge a concept that has dominated the field for >40 years.
https://t.co/rRtg3HFxZ6
The paper: Importance and Assessment of Quality of Life in Symptomatic Permanent #AFib (data from #RATEAF), by @johncamm @tcasl Dr D Koetcha et al, is the Editor’s Choice of issue 10 (145) of Cardiology (@KargerPublisher & @MagdaMuehlemann). Access here: https://t.co/0GhZ5A6R1a
The paper: Importance and Assessment of Quality of Life in Symptomatic Permanent #AFib (data from #RATEAF), by @johncamm @tcasl, Dr D Koetcha et al, is the Editor’s Choice of issue 10 (145) of Cardiology (@KargerPublisher & @MagdaMuehlemann). Access here: https://t.co/AA39pNMVt8
https://t.co/et7nddYVHn - 5 Best Tips for Winning at Pai Gow Poker
#cardgame #cardtips #paigow #PaiGowPoker #poker #pokertips #pokerpro #pokerist #MoneyHeistEP #MoneywebNOW #RateAF #TREASURE #Cashper #Bitcoin
Guys P.S Like, Share & Retweet my Posts.
💗💕😍♥️
#Digoxin now deserves to be considered first-line therapy for long-term heart rate control in older patients with permanent #Afib and symptoms of HF, #RateAF study from #ESCCongress concludes. https://t.co/cLAIB3vv3W
Digoxin now deserves to be considered first-line therapy for long-term heart rate control in older patients with permanent #Afib and symptoms of HF, #RateAF study from #ESCCongress concludes. https://t.co/KTBi3MI038
You never know whose day it’s gonna be! Go digoxin!! #RATEAF
Digoxin after release of the RATE-AF data at #ESCCongress
👆🏽#ESCCongress #RATEAF #Digoxin #AtrialFibrillation
Small trial, cheap drug, mainly older patients with preserved EF and mild symptoms.
How might the results of this RCT change your practice (poll above). 4/4
@HeartOTXHeartMD @paomorejon @GuptaRMD @cpgale3 @StavrosStavrak1
👆🏽#ESCCongress
#RATEAF trial design: https://t.co/rCRMUeDTW9
Findings of #RATEAF a departure from the observational data that has given digoxin a bad rap.
Thoughts?
@DrRaniKhatib @rwyeh @djc795 @DrJasonAndrade @JJheart_doc @mmamas1973 @CarlChiefCard @drdargaray @DrSuzyFeigofsky
👆🏽#ESCCongress
Surprised re findings of #RATEAF?
Time to resurrect #digoxin?
Would you prescribe digoxin over beta-blocker in your patient with #atrialfibrillation and normal EF?
@kamalcardiodoc1 @CarlChiefCard @mmamas1973 @aayshacader @DrJasonAndrade @HeartOTXHeartMD @FZores
#RATEAF #ESCCongress
🔹#digoxin vs #bisoprolol for HR control in #AF (n=160 46%F mostly N EF)
🔹Dig did not improve prim outcome of #QOL at 6 mo
🔹Improved sec outcomes
- NYHA class
- NT-proBNP
🔹Offered similar HR control w/ ⬇️adverse events
Small RCT, cheap drug, impressive!
Patient selection
#RateAF
#ESCCongress
✅Older patients
✅ permanent AF
✅Shortness of breath
✅ > NYHA class II
✅ Baseline HR=100 BPM
#RATEAF
#ESCcongress
❣️N=160
❣️Mean age 76 yo
❣️46%💃
❣️Low dose Digoxin ~161 mcg
❣️For HR/QOL Digoxin = BB
❣️Digoxin Superior for ⬇️ Symptoms, ⬇️ BNP
OLD IS GOLD??
#EPpeeps
Digoxin now deserves to be considered first-line therapy for long-term heart rate control in older patients with permanent #Afib and symptoms of HF, #RateAF study from #ESCCongress concludes. https://t.co/Kzodmeu4Jr
John Mandrola, MD on the surprising results of the RATE-AF trial from the late-breaking session at #ESCCongress. https://t.co/GxnAyU8qpC #digoxin #RATEAF
John Mandrola, MD on the surprising results of the RATE-AF trial from the late-breaking session at #ESCCongress. https://t.co/0Tch6SLqot #digoxin #AFib #RATEAF @drjohnm
Medscape: John Mandrola, MD on the surprising results of the RATE-AF trial from the late-breaking session at #ESCCongress. https://t.co/MM1r0rFmc3 #AFib #RATEAF https://t.co/LHiwz3DBj6
John Mandrola, MD on the surprising results of the RATE-AF trial from the late-breaking session at #ESCCongress. https://t.co/aYUhqKRjaG #AFib #RATEAF
John Mandrola, MD on the surprising results of the RATE-AF trial from the late-breaking session at #ESCCongress. https://t.co/aYUhqKRjaG #AFib #RATEAF
John Mandrola, MD on the surprising results of the RATE-AF trial from the late-breaking session at #ESCCongress. https://t.co/xiWmghe1tm #digoxin #AFib #RATEAF @drjohnm
#RATEAF @ #ESCCongress2020
❤️HR control in permanent #Afib
❤️#digoxin 161 mcg 🆚 #betablocker #bisoprolol
N =160, mean age 76 yr, 46% 👩🏻, 19% #LVEF <50%
QOL & #NYHA ⬆️ w/dig
🤔RCT dig better than real 🌎?
🤔#chronotropic incompetence in #HFpEF?
🦊🧤💛⤵️
https://t.co/UGMmHg8lLn
Most Popular Users
Elon Musk 
@elonmusk
240.4M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
110.1M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.5M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.8M followers
KATY PERRY
@katyperry
87.4M followers
Taylor Swift
@taylorswift13
81.2M followers
Lady Gaga
@ladygaga
72.8M followers
Kim Kardashian
@kimkardashian
69.7M followers
Virat Kohli
@imvkohli
69.5M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
63.7M followers
The Ellen Show
@theellenshow
62.5M followers
Neymar Jr
@neymarjr
62.2M followers
CNN
@cnn
61.9M followers
X
@x
60.8M followers
Selena Gomez
@selenagomez
60.5M followers